Hsa-miR-125b can also inhibit the development of bladder cancer by inhibiting SIRT7 and MALAT1 [37], and has additionally been found to play an essential role in the progression of oral squamous cell cancer (OSCC), as well as the target genes and transcription factors associated with hsa-miR-125b [38]. This evidence concerns the gene SIRT7 and urinary bladder carcinoma.